Thermo Fisher – 2023 new APS classification criteria
Thermo Fisher EliA testing for antiphospholipid syndrome (APS) in relation to the new 2023 APS classification criteria.
27Sep
News
16May
Antiphospholipid Syndrome and EliA APS
Products are for professional/laboratory use only.
Antiphospholipid syndrome (APS) is an autoimmune disease which is characterized by the formation of various antibodies against phospholipids and a blood hypercoagulability.